Curriki

Diagnosis, Targeted therapies: Targeting activators, Sawyer 3

Website Address:https://www.curriki.org/oer/Diagnosis-Targeted-therapies-Targeting-activators-Sawyer-3-255222
member-name
Learning RegistryLearning RegistryDistrict of Columbia, District of Columbia, US,
November 11, 2016
Member Rating
Curriki Rating
'NR' - This resource has not been rated
NR
'NR' - This resource has not been rated

Type:

Other

Description:

Professor Charles Sawyer explains that the CML clone makes mistakes in DNA replication and generates a diverse repertoire of mutations.

Subjects:

    Education Levels:

      Keywords:

      howard hughes medical institute,charles sawyer,NSDL,cancer drug gleevec,NSDL_SetSpec_BEN,dna replication,hiv virus,comprehensive cancer center,mutations,sensitive tools,prostate cancer program,Life Science,oai:nsdl.org:2200/20110722011815505T,prostate cancer,selective pressure,cml patients,gleevec,leukemia,chronic myeloid leukemia

      Language:

      English

      Access Privileges:

      Public - Available to anyone

      License Deed:

      Creative Commons Attribution Non-Commercial Share Alike

      Collections:

      None
      This resource has not yet been aligned.
      Curriki Rating
      'NR' - This resource has not been rated
       NR
      'NR' - This resource has not been rated

      This resource has not yet been reviewed.

      Not Rated Yet.

      View Content
      Professor Charles Sawyer explains that the CML clone makes mistakes in DNA replication and generates a diverse repertoire of mutations.
      ↓http://www.dnalc.org/view/1015-

      CODIE_2017_winner

      Non-profit Tax ID # 203478467